Log in
menu
RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact
All Categories
--------------
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
search
arrow_back_ios
Companies
Metrics
Sources
Topics
Data Sets
Projects
Research Groups
Company Groups
arrow_forward_ios
Home
Companies
Regeneron Pharmaceuticals
history
edit
build
Regeneron Pharmaceuticals
performance profile
WikiRate ID:
49810
Headquarters:
New York (United States)
Website:
https://www.regeneron.com
bookmark
0
Answers
381
Sources
16
Groups
6
Data Sets
7
Details
Filters
filter_list
ALL FILTERS
Answers
381
Metrics
69
calendar_today
Years
15
Sort
Year
Metric
Answer
2022
Comprehensive Income Net of Tax
Research
lock_open
4.13B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Current Income Tax Expense Benefit
Research
lock_open
1.27B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Assets
Research
lock_open
29.2B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Costs and Expenses
Research
lock_open
7.43B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Current Federal Tax Expense (Benefit)
Research
lock_open
969M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Current Foreign Tax Expense Benefit
Research
lock_open
291M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Current State and Local Tax Expense (Benefit)
Research
lock_open
7.4M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Deferred Federal Income Tax Expense (Benefit)
Research
lock_open
-798M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Deferred Foreign Income Tax Expense (Benefit)
Research
lock_open
54M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Deferred Income Tax Expense Benefit
Research
lock_open
-746M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Domestic Income Tax Expense/Benefit
Formula
calculator
976M
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Effective Income Tax Rate Continuing Operations
Research
lock_open
0.11
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Income Loss From Continuing Operations Before Income Taxes Foreign
Research
lock_open
4.02B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Income Tax Expense Benefit
Research
lock_open
520M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Liabilities
Research
lock_open
6.55B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Operating Income (Loss)
Research
lock_open
4.74B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Research and Development Expense
Research
lock_open
3.59B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2022
Unrecognized Tax Benefits that would impact Effective Tax Rate
Research
lock_open
374M
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Address
Research
lock_open
777 OLD SAW MILL RIVER ROAD TARRYTOWN 10591
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
2021
Comprehensive Income Net of Tax
Research
lock_open
8.02B
USD
more_horiz
open_in_full
Open in full page
close_fullscreen
Open in new window
fullscreen
Open in modal
attribution
Attribute
edit
Edit
build
Advanced
«
1
2
3
...
20
»
1 - 20 of 381
file_download
Export
Toggle Dropdown
Export Data
Format
csv
json
Detail
Basic
Extended
Answers
help
up to 50
up to 100
up to 500
up to 1000
up to 5000
Cancel
Export
attribution
Applying Attribution
Using this data requires appropriate attribution.
How to attribute
